Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/9/26

The Vanguard Total Stock Market ETF (VTI), which tracks the broader U.S. stock market, is down 0.16% in early trading on Monday. VTI’s three-month average trading volume stands at 5.20 million shares. Over the past five days, the ETF recorded $868 million in net inflows, signaling continued investor interest. Overall, VTI is down 0.09% over the past five days, but up 1.70% year-to-date.

Claim 55% Off TipRanks

VTI’s Top Holdings

Currently, VTI holds 3,467 stocks with total assets worth $575.08 billion. Its top positions are:

• Nvidia (NVDA) – 6.55%
• Apple (AAPL) – 6.11%
• Microsoft (MSFT) – 5.47%
• Amazon (AMZN) – 3.38%
• Alphabet (GOOGL) – 2.77%

VTI’s Price Forecasts and Holdings

According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of analyst ratings on its holdings, VTI is a Moderate Buy. The Street’s average price target of $410.77 implies an upside of 20.61%. 

Currently, VTI’s five holdings with the highest upside potential are:

1. Quince Therapeutics (QNCX)
2. Bioatla (BCAB)
3. MetaVia (MTVA)
4. NRX Pharmaceuticals (NRXP)
5. Reviva Pharmaceuticals Holdings (RVPH)

Meanwhile, its holdings with the greatest downside potential are:

1. Rallybio (RLYB)
2. ImageneBio (IMA)
3. Loews (L)
4. Core Laboratories (CLB)

Notably, VTI ETF’s Smart Score is seven, implying that this ETF is likely to perform in line with the broader market.